Trends of drug-resistant tuberculosis and risk factors to poor treatment-outcome: a database analysis in Littoral region-Cameroon, 2013–2022

In the Littoral Region-Cameroon, cases of DR-TB increased from 2013, reaching their peak in 2018 befor dropping right up to 2022. RR-TB, MDR-TB, Pre-XDR-TB and XDR-TB represented 3.4%, 94.6%, 1.3% and 0.7% of all reported DR-TB cases. Overall, DR-TB treatment success rate was 87.2%. Male-gender, HIV-positive status, and previous DR-TB are associated with poor TB treatment outcomes. We recommend universal drug susceptibility testing to ensure early/maximum DR-TB case-detection and proper pre-treatment counselling to limit the high death rates and anti-TB treatment refusal rates which are setbacks from achieving end-TB strategies.

Authors

Institutions

Publication Details

Journal
BMC Public Health
Published
2024-11-18
DOI
https://doi.org/10.1186/s12889-024-20585-8
Citations
2
Primary Topic
Tuberculosis Research and Epidemiology
Type
article
Field-Weighted Citation Impact
0.78
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Trends of drug-resistant tuberculosis and risk factors to poor treatment-outcome: a database analysis in Littoral region-Cameroon, 2013–2022

Linda Esso, Laurent-Mireille Endale Mangamba, Valerie Flore Donkeng-Donfack, Georges Alain Etoundi Mballa et al.
2 citations
BMC Public Health
Tuberculosis Research and Epidemiology
0.78
article

Trends of drug-resistant tuberculosis and risk factors to poor treatment-outcome: a database analysis in Littoral region-Cameroon, 2013–2022

Linda Esso, Laurent-Mireille Endale Mangamba, Valerie Flore Donkeng-Donfack, Georges Alain Etoundi Mballa, Teyim Pride Mbuh, Patricia Mendjime, Severin Mefoug, Irene-Adeline Goupeyou-Wandji, Judith Kahou, Patricia Annie Bisso Ngono
article en
2 citations

Abstract

In the Littoral Region-Cameroon, cases of DR-TB increased from 2013, reaching their peak in 2018 befor dropping right up to 2022. RR-TB, MDR-TB, Pre-XDR-TB and XDR-TB represented 3.4%, 94.6%, 1.3% and 0.7% of all reported DR-TB cases. Overall, DR-TB treatment success rate was 87.2%. Male-gender, HIV-positive status, and previous DR-TB are associated with poor TB treatment outcomes. We recommend universal drug susceptibility testing to ensure early/maximum DR-TB case-detection and proper pre-treatment counselling to limit the high death rates and anti-TB treatment refusal rates which are setbacks from achieving end-TB strategies.

BMC Public HealthVol. 24(1)
Yahoo (United Kingdom) (GB), University of Buea (CM), University of Douala (CM), Centre Pasteur du Cameroun (CM), National Radiation Protection Agency of Cameroon (CM), Ministry of Public Health (CM)
Openalex Percentile: Top 26%
Tuberculosis Research and Epidemiology
0.78
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Trends of drug-resistant tuberculosis and risk factors to poor treatment-outcome: a database analysis in Littoral region-Cameroon, 2013–2022 — Linda Esso, Laurent-Mireille Endale Mangamba, et al. · BMC Public Health (2024) | TGRS Research Map | TGRS